Metformin Reduces Long COVID Risk by 41%: New Prevention Strategy

Can a Diabetes Drug Prevent Long COVID?

Taking metformin – a common, affordable diabetes medication – during or soon after infection with the virus that causes COVID-19 may help prevent long COVID, according to compelling evidence reported by Medical News Today on February 9, 2026. The research offers hope for the millions of people worldwide who continue experiencing debilitating symptoms months after their initial COVID-19 infection.

Long COVID, medically termed Post-Acute Sequelae of SARS-CoV-2 infection (PASC), affects an estimated 10-30% of people who contract COVID-19. Symptoms can include extreme fatigue, brain fog, shortness of breath, heart palpitations, and dozens of other manifestations affecting virtually every organ system. The condition has disabled millions worldwide and costs billions in lost productivity and medical expenses.

The discovery that metformin – one of the world’s most prescribed medications, costing as little as $4 per month – might prevent long COVID represents a potential game-changer for public health. Unlike experimental treatments or expensive biologics, metformin is readily available, well-understood, and accessible even in resource-limited settings.

How Does Metformin Prevent Long COVID?

While researchers continue investigating the exact mechanisms, several theories explain metformin’s protective effects:

Anti-Inflammatory Action: Metformin reduces systemic inflammation, a key driver of long COVID symptoms. The medication activates AMP-activated protein kinase (AMPK), a cellular energy regulator that helps control inflammatory responses.

Metabolic Protection: COVID-19 can cause metabolic disruptions that persist long after viral clearance. Metformin helps regulate cellular metabolism, potentially preventing the metabolic dysfunction associated with long COVID.

Antiviral Properties: Emerging evidence suggests metformin may have direct antiviral effects, potentially reducing viral load and limiting tissue damage during acute infection.

Vascular Protection: Long COVID often involves microclotting and vascular dysfunction. Metformin improves endothelial function (blood vessel lining health) and may prevent some vascular complications.

What Does 41% Risk Reduction Mean for Patients?

A 41% reduction in long COVID risk is substantial. To put this in perspective:

Without Metformin: If 100 people get COVID-19, approximately 10-30 might develop long COVID (depending on variant, vaccination status, and other factors).

With Metformin: That same 100 people would see long COVID cases reduced by 41%, meaning instead of 10-30 cases, there might be 6-18 cases.

This represents thousands of prevented long COVID cases globally, as millions continue contracting COVID-19 despite vaccination and previous infection.

Who Should Consider Taking Metformin for COVID-19?

Current Evidence Supports Use For:

• People with type 2 diabetes who contract COVID-19 (already on metformin)
• Non-diabetic individuals with COVID-19 willing to take metformin prophylactically
• Those at high risk for long COVID (previous long COVID, autoimmune conditions, etc.)

Important Considerations: Metformin is a prescription medication. You cannot and should not start taking it without medical supervision. Side effects, though generally mild, can include:

• Gastrointestinal upset (nausea, diarrhea)
• Vitamin B12 deficiency with long-term use
• Rare but serious lactic acidosis (especially in kidney disease patients)

Talk to Your Healthcare Provider If:

• You test positive for COVID-19 and want to discuss metformin
• You’re at high risk for long COVID
• You have pre-existing conditions that might benefit from metformin (prediabetes, PCOS)
• You’re interested in metformin for prevention before potential COVID exposure

When and How Should Metformin Be Taken for Long COVID Prevention?

Based on research protocols:

Timing:

• Start during acute COVID-19 infection
• Or begin soon after positive test (within first few days)
• Continue for 10-14 days typically

Dosing:

• Usually 500-1500mg daily (divided doses)
• Start with lower dose to minimize GI side effects
• Increase gradually as tolerated

Important: These are general guidelines from research studies – your healthcare provider will determine appropriate dosing for your individual situation.

Public Health Message: Affordable Prevention for Long COVID

Long COVID has devastated millions of lives, causing job loss, disability, and profound suffering. The possibility that a $4-per-month medication might prevent 41% of cases represents extraordinary hope, especially for people in countries or situations where expensive treatments remain inaccessible.

If you contract COVID-19, discuss metformin with your healthcare provider immediately – don’t wait to see if you develop long COVID symptoms. Prevention is far easier than treatment, and early intervention during acute infection offers the best protection.

For people with diabetes already taking metformin, this research provides additional reassurance about your medication’s benefits. Continue taking metformin as prescribed, which may offer COVID protection alongside its blood sugar benefits.

As with any emerging treatment approach, more research is needed to optimize protocols and understand who benefits most. However, given metformin’s excellent safety profile, widespread availability, and low cost, this represents one of the most accessible long COVID prevention strategies discovered to date.